Drugs / PRT042
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07193901 | May 2025 → Jun 2026 overdue | major depressive disorder | Sichuan Purity Pharmaceutical Technology Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRT042 | “To evaluate the efficacy of PRT-042 nasal spray for the Rapid Reduction of the depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation...” NCT07193901 ↗1“Low Dose PRT042 nasal spray” NCT07193901 ↗ |
| Route | Intranasal | “PRT042 nasal spray” NCT07193901 ↗ |